Owlet, Inc. OWLT
Owlet is a leading pediatric health platform and the only company globally to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors for home use. By delivering hospital-grade technology through a consumer-friendly interface, we bridge the critical gap between clinical care and the home.
Our ecosystem—comprising clinically tested monitoring systems, an integrated video platform, and an intuitive mobile app—supports families from "night one" and throughout the most challenging parts of the parenting journey. Since 2012, more than 2.5 million parents have trusted Owlet to provide the real-time insights in support of their child's well-being and to promote restful sleep for the entire family.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $105.7M | $78.1M | $54.0M | $69.2M | $75.8M | $75.4M | — |
| Cost of revenue | $52.2M | $38.7M | $31.4M | $45.9M | $40.8M | $39.5M | — |
| Gross profit | $53.5M | $39.3M | $22.6M | $23.3M | $35.1M | $35.9M | — |
| R&D | $14.1M | $9.8M | $10.3M | $27.9M | $21.4M | $10.5M | — |
| SG&A | $29.2M | $34.0M | $27.3M | $41.5M | $32.3M | $13.1M | — |
| Total operating expenses | $61.8M | $59.5M | $51.2M | $107.9M | $90.8M | $42.9M | — |
| Operating income | -$8.3M | -$20.2M | -$28.6M | -$84.6M | -$55.8M | -$7.0M | — |
| Interest expense | — | $1.6M | $3.2M | $1.1M | $1.8M | $1.4M | — |
| Pre-tax income | -$39.6M | -$12.5M | -$32.9M | -$79.3M | -$71.7M | -$10.5M | — |
| Income tax | $28.0K | $54.0K | $10.0K | $29.0K | $31.0K | $20.0K | — |
| Net income | -$39.7M | -$12.5M | -$32.9M | -$79.3M | -$71.7M | -$10.5M | — |
| EPS, basic | -2.31 | -1.57 | -4.53 | -9.98 | -1.13 | -0.48 | — |
| EPS, diluted | — | -1.57 | -4.53 | -9.98 | -1.13 | -0.48 | — |
| Shares, diluted (wtd. avg.) | $18.1M | $11.0M | $8.3M | $8.0M | $63.2M | $22.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $35.5M | $20.2M | $16.6M | $11.2M | $95.1M | $17.0M | $11.7M |
| Receivables | $22.9M | $12.1M | $14.0M | $16.0M | $10.5M | $10.5M | — |
| Inventory | $15.3M | $10.5M | $6.5M | $18.5M | $18.0M | $7.9M | — |
| Total current assets | $81.9M | $46.1M | $39.9M | $51.3M | $135.8M | $37.6M | — |
| Property, plant and equipment | $295.0K | $102.0K | $377.0K | $1.1M | $1.9M | $1.7M | — |
| Other intangibles | $1.4M | $975.0K | $2.2M | $2.3M | $1.7M | $605.0K | — |
| Total assets | $85.6M | $49.5M | $44.1M | $58.1M | $140.0M | $40.1M | — |
| Accounts payable | $12.0M | $11.3M | $13.7M | $30.4M | $27.8M | $16.4M | — |
| Short-term debt | $10.6M | $7.4M | $15.2M | $10.4M | $8.5M | $2.0M | — |
| Total current liabilities | $44.2M | $36.4M | $45.1M | $66.6M | $69.1M | $47.3M | — |
| Long-term debt | $2.5M | $4.3M | $0 | $0 | $8.0M | $10.2M | — |
| Total liabilities | $50.2M | $66.3M | $73.8M | $68.7M | $84.9M | $60.9M | — |
| Retained earnings | -$307.9M | -$268.2M | -$255.7M | -$222.8M | -$143.4M | -$71.7M | — |
| Total equity | $19.0M | -$29.8M | -$37.5M | -$10.6M | $55.2M | -$68.0M | -$58.9M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.8M | -$11.2M | -$23.5M | -$81.4M | -$40.6M | -$129.0K | — |
| Depreciation and amortisation | $521.0K | $452.0K | $842.0K | $1.4M | $1.1M | $873.0K | — |
| Stock-based compensation | $9.3M | $8.6M | $9.9M | $12.9M | $4.3M | $1.1M | — |
| Capital expenditure | $273.0K | $35.0K | $16.0K | $636.0K | $969.0K | $967.0K | — |
| Investing cash flow | -$943.0K | -$761.0K | -$59.0K | -$1.6M | -$2.0M | -$1.1M | — |
| Financing cash flow | $32.1M | $16.0M | $28.9M | -$878.0K | $120.6M | $6.5M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001816708-26-000063.
Others in SIC 3829
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC. | $226.94B | 34.6x | 3.9% |
| ROK | ROCKWELL AUTOMATION, INC | $48.17B | 56.6x | 0.9% |
| TRMB | TRIMBLE INC. | $13.87B | 33.8x | -2.6% |
| ONTO | ONTO INNOVATION INC. | $13.15B | 96.4x | 1.8% |
| MIR | Mirion Technologies, Inc. | $4.14B | 153.9x | 7.5% |
| QSI | Quantum-Si Inc | $166.8M | — | -20.3% |
| GEOS | GEOSPACE TECHNOLOGIES CORP | $69.6M | — | -18.3% |
| BCHT | Birchtech Corp. | $31.3M | — | 1.3% |